Approvals/TGA/OLAMLO HCT 40/5/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/5/12.5 mg film-coated tablet blister pack

Approved

STANDARD

OLAMLO HCT 40/5/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/5/12.5 mg film-coated tablet blister pack

Accord Healthcare Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 11084ecc3b0d1d1f
Product Name: OLAMLO HCT 40/5/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/5/12.5 mg film-coated tablet blister pack
Artg Id: 312003
Artg Name: OLAMLO HCT 40/5/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/5/12.5 mg film-coated tablet blister pack
Sponsor: Accord Healthcare Pty Ltd
Company Detail Path: /organization/accord-healthcare-pty-ltd
Artg Date: 2019-11-21
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/4a781407a821229ce6a43df36ef7a530.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/627f347c784d62e06a0061eae5cd804e.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

11084ecc3b0d1d1f

Type

Standard